Our research and development team consists of world leading experts in the fields of drug development, clinical research, psychiatry, and psychotherapy.
This team, building on its own substantial innovative research, supported by experienced consultants and a network of leading international contract/clinical research organisations, is building a pipeline of new therapies and drug candidates (designed to be used in conjunction with psychotherapy). We focus our research and development activities on treating addictions where the consequences for the patient, their family and society are at present most severe, with near, medium, and long terms programs.
Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
MDMA-Assisted Psychotherapy for Alcohol Use Disorder
New Chemical Entities
Alcohol, Behavioural, Opioid, and Tobacco addictions
Sign Up for Newsletter: